Other Clinical Trial - Quality of Life Intermittent Catheter Study

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Neurogenic Bladder Dysfunction Nos
Urinary Bladder, Neurogenic

See also
Status	Clinical Trial	Phase
Terminated	`NCT00711087` - Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)	Phase 2
Not yet recruiting	`NCT03280186` - Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention	N/A
Completed	`NCT01389921` - Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT00711087 - Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)

Phase 2

Not yet recruiting

NCT03280186 - Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention

N/A

Completed

NCT01389921 - Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01523743
Study type	Interventional
Source	Coloplast A/S
Contact
Status	Completed
Phase	Phase 4
Start date	November 2011
Completion date	May 2012

Quality of Life Intermittent Catheter Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms